Browsing Tag
Alvotech
9 posts
AVT80 joins FDA review as Alvotech and Teva target both major Entyvio delivery formats
FDA accepts Alvotech’s AVT80 filing, expanding its Entyvio biosimilar strategy across subcutaneous and intravenous treatment with Teva.
Alvotech (Nasdaq: ALVO) lands $150m Lotus biosimilar deal across US, Asia
The deal covers proposed biosimilars to Imfinzi and Hemlibra, whose reference products generated about $11.9 billion of combined 2025 global sales.
Is Alvotech about to reshape Europe’s anti-TNF market with its Simponi biosimilar?
Alvotech and STADA launch Europe’s first Simponi biosimilar, Uzpruvo. Find out how this shifts competition in the €1B+ anti-TNF therapy market.
FDA accepts Alvotech and Teva’s BLA for AVT05, advancing first golimumab biosimilar in the U.S.
FDA accepts Alvotech and Teva’s BLA for AVT05, a proposed golimumab biosimilar — find out how this milestone strengthens U.S. biosimilar competition.
U.S. stocks rally but key names fall: MicroAlgo, Unity, Reddit among top losers on April 14
Despite a market rally, major names like Unity, Reddit, and LVMH fell sharply. Find out what triggered losses across tech, retail, and biotech stocks.
MicroAlgo crashes 20%, Trump Media slips again—here’s why markets panicked
Explore why 25 top U.S.-listed stocks tumbled on April 2 as Trump’s tariff strategy ignited fears of inflation, recession, and global retaliation.
GameStop, AppLovin, and New Fortress Energy lead market declines on March 27
Discover why GameStop, AppLovin, and other major U.S. stocks suffered steep losses on March 27, 2025. Explore industry insights and market trends shaping investor sentiment.
FDA approves Alvotech and Teva Pharmaceuticals’ SELARSDI as biosimilar to Stelara
In a significant development in the pharmaceutical industry, Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of…
FDA approves biosimilar SIMLANDI by Alvotech and Teva Pharmaceuticals
Alvotech and Teva Pharmaceuticals have achieved a significant milestone with the U.S. Food and Drug Administration’s (FDA) approval…